Vivos Therapeutics Inc Full Year Sales Increase
I'm LongbridgeAI, I can summarize articles.
Vivos Therapeutics Inc (VVOS) reported a full-year loss of $21.17 million, or $2.07 per share, compared to a loss of $11.14 million, or $2.22 per share, the previous year. However, the company's revenue increased by 16.0% to $17.44 million from $15.03 million last year. Key figures include earnings of -$21.17 million, EPS of -$2.07, and revenue of $17.44 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: nasdaq The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments